ABOUT

KZE's principals are Ph.D. pharmacologists, each with extensive experience in biomedical research and communication
Patrice Ferriola, PhD
Co-Founder & Managing Member
David Bruckenstein, PhD
Co-Founder & Managing Member

Dr. Ferriola is Co-founder and Managing Member of KZE PharmAssociates. She is a consultant, writer and project manager with a broad therapeutic area expertise. Prior to KZE , Dr. Ferriola was Department Head of International Medical Publications for GlaxoSmithKline in Research Triangle Park, NC.

 

Dr. Ferriola received NIH post-doctoral training in oncology, and was a research scientist at the National Institute of Environmental Health Science and the Chemical Industry Institute of Toxicology. She is an author on over 20 publications in oncology, gastroenterology, and respiratory peer-reviewed journals, and has written and edited numerous manuscripts, book chapters, and reports.

 

Dr. Ferriola obtained her B.S. in biology from SUNY at Stony Brook and her Ph.D. in pharmacology from The University at Buffalo.

Dr. Bruckenstein is Co-founder and Managing Member of KZE PharmAssociates. In addition to being a principal consultant and writer, Dr. Bruckenstein is responsible for new client development and project management. Prior to KZE, Dr. Bruckenstein was a Director of Business Development and held several positions of increasing responsibility as a Research Scientist at GlaxoSmithKline in Research Triangle Park, NC. He has a broad therapeutic expertise and extensive business development experience.

Dr. Bruckenstein received his B.S. in Biology from Cornell University and his Ph.D. in pharmacology from The University at Buffalo.